scorecardresearch
Friday, July 18, 2025
TopicDrug regulation in India

Topic: Drug regulation in India

Antibiotics launched in India will soon need CDSCO nod as drug resistance emerges as silent killer

In 2019, bacterial antimicrobial resistance killed between 3 lakh and 10.4 lakh people in India, according to a Lancet report.

Govt approves 50% price rise for 8 essential drugs after manufacturers say production is ‘unviable’

Asthma, glaucoma, thalassemia, tuberculosis, and mental health patients require the drugs in question.

Health ministry bans FDCs every few years. Ask how they enter the market in the first place

The medical rationale behind fixed-dose combination drugs soon gave into commercial interests that cared little for the health of patients. Government's only response has been to keep issuing ban orders since 1983.

Govt panel urges regulator to approve import of American drug for diabetes, obesity

Lilly's Mounjaro is a popular choice for weight loss. Mounjaro is expected to launch in India in India in 2025.

Drug regulator gives conditional nod for sale of 5 FDCs, seeks efficacy & safety data for 3 of them

Popular brands using combinations under the scanner include D Cold Total and Dolo Cold. The five FDCs are part of 344 drug combinations that the government had first banned in 2016.

Jailed in Punjab, acquitted in Bengal—How judiciary handled drug law violations

In 'Truth Pill: The Myth of Drug Regulation in India', authors Dinesh S. Thakur and Prashant Reddy T. expose the faulty drug regulation in India.

‘Feeding cough syrup seems like Russian roulette’—new book exposes drug regulation in India

Dinesh S. Thakur and Prashant Reddy tapped into the nitty gritty of drug regulation, cough syrups and medicines in India at the launch of their book ‘Truth Pill’ in Delhi.

On Camera

Critical minerals are the new oil. India can’t afford to depend on China

Mineral security is no longer just an economic concern but a national security imperative, underpinning the country’s ambitions in clean energy, defence self-reliance, and advanced manufacturing.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

RSS chief Bhagwat draws the line at 75. India’s politics stares at the Modi Exception

BJP has no dynastic succession, at least not at the top. You can trace this back to Vajpayee-Advani era. This act of spotting, empowering younger talent is even more striking with the choice of BJP presidents.